GlobalData analysed the product launch and withdrawal trends using its POLI database, comparing activity in the ten months ...

While there are currently no approved perioperative treatments for liver cancer, multiple late-stage trials are evaluating ...

Gilead acquired Arcellx to gain the development and marketing rights to anito-cel, for which GlobalData forecasts sales of ...

Viz.ai has entered a collaboration with Alnylam to advance earlier identification and streamline diagnosis for cardiac ...

MSD has signed a multi-year research collaboration with Quotient Therapeutics to discover new drug targets for IBD.

Terns’ lead candidate has demonstrated “unprecedented data” in chronic myeloid leukaemia, according to analysts.

Pharmaceutical R&D is falling increasingly to artificial intelligence (AI)-guided autonomous laboratories, and the people behind them say the role of human researchers may soon be ...

The $2bn site will reside in the same state as UCB’s US HQ in Smyrna, and will produce biologics from the company's portfolio ...

The healthcare landscape has undergone a rapid transformation worldwide over the past decade. COVID-19 played a massive role ...

Gilead may collaborate with Galapagos to develop Ouro's in-licensed gamgertamig for the treatment of B-cell mediated ...

Sanofi and Kali Therapeutics have signed an exclusive global licence agreement for KT501, a new tri-specific antibody for B ...

Backed by partner Sanofi, Earendil will expand the utility of its AI-driven drug discovery platform, while progressing its ...